Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinoma
Not Applicable
- Conditions
- oral squamous cell carcinoma
- Registration Number
- JPRN-UMIN000033453
- Lead Sponsor
- agasaki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient who is a local recurrence case 2. Patient other than primary case. 3. In addition, patients whose research managers judged inappropriate as subjects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5 year Overall survival
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted in postoperative adjuvant therapies for locally advanced oral squamous cell carcinoma?
How does the observational design of JPRN-UMIN000033453 compare to randomized trials of adjuvant chemotherapy in OSCC?
Which biomarkers correlate with improved survival in adjuvant treatment of p16-negative oral squamous cell carcinoma?
What adverse event profiles are reported in adjuvant radiotherapy versus chemoradiotherapy for locally advanced OSCC?
What combination therapies are being explored for postoperative management of HPV-negative oral squamous cell carcinoma?